诊断

To diagnose uterine sarcoma, you may need a physical exam, imaging tests and testing of a tissue sample, called a biopsy.

Before surgery, it can be hard to tell a uterine sarcoma from a uterine fibroid. Fibroids are noncancerous growths of uterine muscle. Sarcomas are cancer. The two can cause similar symptoms and can look alike on imaging tests.

Imaging tests

An ultrasound often is one of the first tests used to look at a growth in the uterus. It can show the growth's size and location. But an ultrasound alone typically cannot confirm whether a growth is a fibroid or a uterine sarcoma.

An MRI can give more detail about a growth in the uterus. Some MRI findings may suggest sarcoma. Even so, fibroids and sarcomas can look alike. A final diagnosis still requires examination of tumor tissue.

Other imaging tests, such as a CT scan, may be used to look for cancer that has spread.

Tissue testing

A doctor called a pathologist examines tumor tissue under a microscope. This shows whether the tissue is cancer. If it is cancer, it shows what type of uterine sarcoma it is. For some people, uterine sarcoma is found after surgery for what was thought to be a fibroid or another noncancerous condition.

Tests on the tumor also may look for hormone receptors or gene changes. The results can help guide treatment.

Grades

Grade describes what the cancer cells look like and gives clues about how quickly the cancer may grow and spread. Grade and stage are different. Grade describes the cancer cells. Stage refers to how much cancer is in the body and whether it has spread.

Grade is especially important for endometrial stromal sarcoma (ESS). ESS may be low grade or high grade.

  • Low-grade ESS. This type generally grows slowly. These tumors often have estrogen and progesterone receptors. This may make hormone therapy a treatment option. Low-grade ESS can come back many years after treatment, so long-term follow-up may be needed.
  • High-grade ESS. This type tends to grow and spread more quickly. The outlook is generally less favorable than for low-grade ESS. High-grade ESS is more often found when the tumor is already large or has spread. The outlook also depends on how far the cancer has spread.

Other types of uterine sarcoma do not always fit into the same low-grade and high-grade groups used for ESS. Your care team can explain whether grade is important for your type of uterine sarcoma and what it means for you.

治疗

Treatment for uterine sarcoma depends on the type, grade and stage of the cancer. Your health and preferences matter too.

Your care may involve several cancer specialists. A gynecologic oncologist treats cancers of the reproductive system. A medical oncologist treats cancer with medicines. A radiation oncologist treats cancer with radiation.

Surgery

Surgery is the main treatment for most uterine sarcomas that are limited to the uterus and can be completely removed. A total hysterectomy removes the uterus and cervix. The surgery may be done through an incision in the abdomen, called an abdominal hysterectomy. The ovaries and fallopian tubes also may be removed. This depends on the type of sarcoma and your circumstances.

Nearby lymph nodes are not removed as part of every uterine sarcoma surgery. They may be removed if imaging or surgery shows that the lymph nodes appear to have cancer.

Chemotherapy

Chemotherapy uses medicines that kill cancer cells. It may be used for some high-grade, advanced or recurrent uterine sarcomas. Recurrent means the cancer has come back after treatment.

Treatment differs by type. Chemotherapy usually is not the first treatment used for low-grade ESS because it typically doesn't work.

Hormone therapy

Hormone therapy is used mainly for low-grade ESS. These cancers often have receptors for estrogen and progesterone, hormones that can affect how the cancer grows. Hormone therapy works by lowering estrogen levels or blocking the effects of hormones on the cancer.

Depending on the medicine, hormone therapy may be taken as a pill or given as an injection. Because these treatments change or block the effects of reproductive hormones, their side effects can be more significant than side effects commonly associated with hormonal birth control. Possible effects include hot flashes, vaginal dryness, fatigue, lower sexual desire, joint or muscle pain, and bone thinning. Some progestins also can cause increased appetite, weight gain and changes in blood sugar. Rarely, they can cause blood clots.

Radiation therapy

Radiation therapy uses high-energy beams or particles to damage cancer cells. It may be used after surgery in some situations, when surgery is not possible or to ease symptoms from advanced cancer.

Radiation may lower the chance that some uterine sarcomas will return in the pelvis. But the available evidence does not clearly show that radiation helps people live longer.

Targeted therapy and immunotherapy

Targeted medicines act on specific features of cancer cells. Immunotherapy helps the immune system recognize or attack cancer cells.

These treatments may be options for some advanced uterine sarcomas or cancers that have come back. The options depend on the cancer subtype and tumor test results.

临床试验

探索 Mayo Clinic 的研究 测试新的治疗、干预与检查方法,旨在预防、检测、治疗或控制这种疾病。

妥善处理与支持

Learning that you have uterine sarcoma can bring a lot of new information at once. You do not need to understand everything right away. Your care team will help you learn what type of uterine sarcoma you have and what it means for your care.

Living with a rare cancer can bring uncertainty and stress. Learning about your type of uterine sarcoma and writing down questions for your care team may help. Ask your cancer care team about support and services that fit your needs. These may include counseling, oncology social work, cancer or sarcoma support groups, and peer support. Your care team also can help with practical concerns related to treatment and follow-up.

准备您的预约

If you have symptoms that may be caused by uterine sarcoma, you may first see a healthcare professional who provides gynecologic care. If cancer is suspected or diagnosed, you may be referred to a gynecologic oncologist.

What you can do

Before your appointment:

  • Write down your symptoms, when they started and whether they have changed.
  • Make a list of the medicines, vitamins and supplements you take.
  • Write down any previous cancer treatments, including radiation therapy or tamoxifen.
  • Gather information about cancers or inherited cancer syndromes in your family.
  • Write down questions you want to ask.
  • Consider bringing someone you trust to your appointment. Choose someone who is a good listener and can help take notes. Having another person listen and take notes may help you remember and understand what was discussed.

Questions to ask may include:

  • What type of uterine sarcoma do I have?
  • What is the cancer's grade?
  • What is the cancer's stage?
  • Has the cancer spread outside the uterus?
  • What tests do I need?
  • What treatment do you recommend and why?
  • Do I need to see other cancer specialists?
  • Should I consider a clinical trial?
  • What does my diagnosis mean for my outlook?
  • Is genetic counseling or genetic testing right for me?
  • Where can I find support for people with sarcoma?

What to expect from your doctor

Your healthcare professional may ask:

  • When did your symptoms begin?
  • Have the symptoms changed over time?
  • Have you had vaginal bleeding after menopause or bleeding between periods?
  • Have you noticed pelvic pain, pressure or a lump?
  • Have you had radiation therapy to the pelvis?
  • Have you taken tamoxifen?
  • Have any close biological relatives had sarcoma or an inherited cancer syndrome?
Aug. 22, 2026
  1. Abu-Rustum NR, et al. NCCN Guidelines Insights: Uterine neoplasms, version 3.2025. Journal of the National Comprehensive Cancer Network. 2025; doi:10.6004/jnccn.2025.0038.
  2. Uterine sarcoma treatment. National Cancer Institute. (PDQ) — Health Professional Version. National Cancer Institute. https://www.cancer.gov/types/uterine/hp/uterine-sarcoma-treatment-pdq. Accessed Aug. 10, 2026.
  3. Lewis D, et al. Current treatment options: Uterine sarcoma. Current Treatment Options in Oncology. 2024; doi:10.1007/s11864-024-01214-3.
  4. Raffone A, et al. Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: A systematic review and meta-analysis. International Journal of Gynecology & Obstetrics. 2024; doi:10.1002/ijgo.15136.
  5. Woo S, et al. Utility of ADC values for differentiating uterine sarcomas from leiomyomas: Systematic review and meta-analysis. AJR American Journal of Roentgenology. 2024; doi:10.2214/AJR.24.31280.
  6. Dermawan JK, et al. The impact of Li-Fraumeni and germline retinoblastoma mutations on leiomyosarcoma initiation, outcomes, and genetic testing recommendations. Clinical Cancer Research. 2024; doi:10.1158/1078-0432.CCR-24-1160.
  7. Mancari R, et al. Prognostic factors in uterine adenosarcoma: Subanalysis of the SARCUT study. Frontiers in Oncology. 2024; doi:10.3389/fonc.2024.1393707.
  8. Zapardiel I, et al. Prognostic factors in patients with uterine sarcoma: The SARCUT study. International Journal of Gynecological Cancer. 2023; doi:10.1136/ijgc-2022-004204.
  9. Istl AC, et al. Treatment patterns and outcomes for primary uterine leiomyosarcoma with synchronous isolated lung metastases: A National Cancer Database study of primary resection and metastasectomy. Gynecologic Oncology Reports. 2024; doi:10.1016/j.gore.2023.101308.
  10. Ricotta G, et al. Endometrial stromal sarcoma: An update. Cancers. 2025; doi:10.3390/cancers17111893.
  11. Devins KM, et al. Low-grade endometrial stromal sarcoma: Clinicopathologic and prognostic features in a cohort of 102 tumors. American Journal of Surgical Pathology. 2025; doi:10.1097/PAS.0000000000002428.
  12. American Cancer Society. Uterine sarcoma. https://www.cancer.org/content/dam/CRC/PDF/Public/9879.00.pdf. Accessed Aug. 10, 2026.

相关